Is Zantac, specifically ranitidine-based Zantac, still under recall in the United States, Canada, and other major countries as of today’s date in 2024? I understand it was initially recalled due to concerns about NDMA contamination, a probable human carcinogen. I’m interested in knowing if the recall is still active, if there have been any changes in the scope or status of the recall since the initial announcement, and what the current recommendations are for individuals who previously used or are still in possession of Zantac products? Furthermore, have there been any significant legal developments or settlements related to the Zantac recall that would impact consumers?
Answer
Yes, Zantac (ranitidine) is still recalled in 2024.
Details of the Recall:
- Initial Recall: The initial recalls of Zantac and generic ranitidine products began in 2019.
- Reason for Recall: The recalls were initiated due to the discovery of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in ranitidine products. NDMA levels were found to increase in some products over time and when stored at higher temperatures.
- FDA Action: The U.S. Food and Drug Administration (FDA) requested manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine products from the market in April 2020.
- Ongoing Litigation: The Zantac recall has resulted in numerous lawsuits alleging that the use of Zantac caused cancer. These lawsuits are ongoing.
- Current Market Status: Ranitidine is no longer available as a prescription or OTC medication in the United States. Alternative medications are available.
- Further Considerations: While ranitidine itself is no longer available, it’s crucial to dispose of any remaining Zantac or ranitidine products safely. Consult with a healthcare professional if you have concerns about past Zantac use.